Inventor · disambiguated record
Gregorio Fernandez Ballester
Also filed as: FERNANDEZ BALLESTER GREGORIO · FERNANDEZ BALLESTER GREGORIO JOAQUIN · FERNÁNDEZ BALLESTER GREGORIO
8 granted patents·38 citations·filing 2006–2019
81Inventor score
Files withLUBRIZOL ADVANCED MAT INC3AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO—A C R A F S P A2GARCIA SANZ NURIA1LIPOTEC SA1LIPOTRUE S L1
Top patents by PatentIndex Score
8 records- 0193US8946166B2Peptide-based compounds and compositions which inhibit muscle contractionGARCIA SANZ NURIA·Filed 2010·Granted Feb 3, 2015·20 cites·22 claims
- 0281US9771392B2Compounds which inhibit neuronal exocytosisLUBRIZOL ADVANCED MAT INC·Filed 2013·Granted Sep 26, 2017·6 cites·13 claims
- 0377US7473679B2Treatments employing neuronal exocytosis-inhibiting peptidesLIPOTEC SA·Filed 2006·Granted Jan 6, 2009·10 cites·10 claims
- 0466US9393187B2Peptide compounds that inhibit neuronal exocytosisLUBRIZOL ADVANCED MAT INC·Filed 2013·Granted Jul 19, 2016·1 cites·21 claims
- 0564US10035820B2Compounds which inhibit neuronal exocytosisLUBRIZOL ADVANCED MAT INC·Filed 2013·Granted Jul 31, 2018·1 cites·15 claims
- 0656US12377035B2Peptides for inhibiting cholinergic calcitonin gene-related peptide (CGRP) and acetylcholine (ACH) release or inhibiting sensitization-mediated by TRPV1-mediated excitability in sensory neurons and methods of use thereofAZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO—A C R A F S P A·Filed 2019·Granted Aug 5, 2025·0 cites·20 claims
- 0744US12102705B2Peptides having inhibitory activity on muscarinic receptor M3AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO—A C R A F S P A·Filed 2019·Granted Oct 1, 2024·0 cites·18 claims
- 0834US11634458B2Peptides and compositions for use in cosmetics and medicineLIPOTRUE S L·Filed 2019·Granted Apr 25, 2023·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Gregorio Fernandez Ballester files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →